SCHEMBL22985261

SCHEMBL22985261

Cc1cccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(C#N)c(-c3cc(-c4ccc(C(F)(F)F)cc4C#N)ccc3-n3c4ccccc4c4cc(-c5cccc(C)c5)ccc43)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.41
XDH P47989 1/20 0.35
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
ICMT O60725 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
BCAT1 P54687 1/20 0.32
KIF11 P52732 1/20 0.31
ENPP1 P22413 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985262 0.97 AR (0.43) ARXDHALOX5APFEN1ICMT
SCHEMBL22985458 0.94 ALOX5AP (0.35) ARXDHALOX5APFEN1BCAT1
SCHEMBL20848486 0.94 AR (0.44) ARICMTBCAT1CYP2C9
SCHEMBL22985265 0.93 AR (0.38) ARXDHALOX5APFEN1ICMT
SCHEMBL22985654 0.93 ALOX5AP (0.36) ARXDHALOX5APFEN1GABRA1
SCHEMBL22985414 0.92 ALOX5AP (0.37) ARXDHALOX5APFEN1GABRA1
SCHEMBL22985456 0.92 AR (0.36) ARXDHALOX5APFEN1BCAT1
SCHEMBL22985210 0.91 PTPN5 (0.36) XDHALOX5APFEN1GABRA1GABRG2
SCHEMBL20848688 0.91 AR (0.43) ARICMTBCAT1ALDH1A1HPGD
SCHEMBL22985206 0.91 ALOX5AP (0.38) ARXDHALOX5APFEN1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 AR 3541/4885XDH 1167/4885ALOX5AP 2567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.